Ark Invest, led by Cathie Wood, issued another "Big Ideas" list on Wednesday, sharing themes for 2026 that investors should ...
The ARK Genomic Revolution ETF remains a "Buy" as it beats SPY/XLV, shows bullish breakout signals, and targets $42. Learn more about the fund.
In the biotech space, ARK acquired 127,184 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) through its ARKK and ARKG ETFs, ...
Cathie Wood’s ARK ETF published their daily trades for Thursday, January 15, 2026, revealing a continued focus on Intellia Therapeutics Inc (NASDAQ:NTLA). The firm purchased a total of 56,769 shares ...
ARK Invest bought $7.27M Netflix stock and sold $4.19M Beam Therapeutics on Jan 21, 2026. Full breakdown of Cathie Wood's ...
11d
Cathie Wood Doubles Down On Netflix Despite Weak Guidance, Ark Invest Dumps This Social Media Stock
On Wednesday, Jan. 21, 2026, Cathie Wood-led Ark Invest bought $7.11 million in Netflix shares, but sold shares of Pinterest.
Cathie Wood’s ARK Invest expanded its crypto bets again this week, increasing its stake in exchange Bullish by more than 105,000 shares, worth about $5.3 million. The purchase, spread across ARK's ...
In the latest trading session, Cathie Wood's ARK ETFs continued to adjust their portfolios, with significant moves seen in both buying and selling across various sectors. The largest transaction for ...
Cathie Wood’s ARK Fintech Innovation ETF (ARKF) posted a 29% return in 2025, contrasting sharply with a broader fintech sector downturn. This performance stemmed from strategic shifts toward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results